News: Biotechnology  |  Nanotechnology  |  Pharmaceutical  |  >Clinical Trials  |  Genetics

Clinical Trials News Today is August 28, 2008. All times in Eastern Daylight Time. 08/28/2008 - 11:46 AM Hi-Tech Pharmacal Files Suit to Confirm the Company's Market Exclusivity Status Regarding Dorzolamide and Timolol Ophthalmic Solution 08/28/2008 - 09:40 AM CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving(R) System for Percutaneous Aortic Valve Replacement 08/28/2008 - 08:30 AM The CYPHER(R) Sirolimus-eluting Coronary Stent Outperforms the Taxus(R) Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology 08/28/2008 - 08:30 AM ThermoDox(R) Liver Cancer Study Phase I Results to Be Presented at ILCA Conference 2008 08/28/2008 - 08:00 AM Valeant Pharmaceuticals and GlaxoSmithKline Announce Worldwide Collaboration Agreement for Retigabine 08/28/2008 - 08:00 AM Curis Announces GDC-0449 Phase II Ovarian Cancer Trial Design 08/28/2008 - 06:00 AM Illumina to Present at Upcoming Investment Conferences in September 08/27/2008 - 04:30 PM Neurogen Corporation Receives Notification from Nasdaq 08/27/2008 - 02:00 PM Media Advisory: International Symposium on Human Identification Features Latest Advances and Applications in DNA Testing 08/27/2008 - 10:02 AM SeraCare Life Sciences to Present at Thomas Weisel Partners Healthcare Conference 08/27/2008 - 09:03 AM Maxygen Receives $3.4 Million Government Grant to Develop Vaccine Discovery Technology 08/27/2008 - 09:00 AM Seattle Genetics to Present at Upcoming Investor Conferences 08/27/2008 - 09:00 AM FDA Grants CLIA Waiver to ABMC for Its Drug Test 08/27/2008 - 07:10 AM Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer 08/27/2008 - 07:00 AM Tepnel Announces New DNA Test for Early Detection of Familial Hypercholesterolaemia 08/27/2008 - 06:30 AM XDx's AlloMap(R) Gene Expression Test Cleared by U.S. Food and Drug Administration (FDA) 08/27/2008 - 06:00 AM CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks 08/27/2008 - 04:00 AM LGC Invests in Fluidigm's Integrated Fluidic Circuit Technology 08/26/2008 - 04:15 PM NexMed Announces Decision for NM100060 08/26/2008 - 04:15 PM Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program 08/26/2008 - 03:30 PM ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology 08/26/2008 - 03:00 PM ProTrials Makes The Inc. 5000, Reflecting Three-Year Sales Growth 08/26/2008 - 12:10 PM BIOTRONIK: EchoCRT, the Largest Trial of Its Kind, Enrolls First Patients Today 08/26/2008 - 09:38 AM Professor John F. Thompson to Present at Perspectives in Melanoma XII, Thursday October 2, 2008 08/26/2008 - 09:00 AM Morphotek(R), Inc. Expands Its Phase II Trial Site Selections in the European Union 1 2 3   NEXT »

Terms of Use   |   ©2008 Business Wire